Clinical Trial Update: Celecoxib as Adjuvant Therapy to Chemotherapy in Patients With Metastatic Colorectal Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating celecoxib as adjuvant therapy to chemotherapy in patients with metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Colon Cancer Stage | Phase 4 | Status: UNKNOWN